Cancer Research & Therapy 2026
2nd International Conference on Cancer Research & Therapy 2026
June 05-06, 2026 | Online Event | London, UK
Theme: “Precision Oncology: Advancing Personalized Cancer Care Worldwide”
2nd International Conference on Cancer Research & Therapy 2026
June 05–06 2026 | Online Event
International Conference on Cancer Research & Therapy (CRT-2026) is the premier international platform uniting oncology leaders, researchers, and healthcare innovators to accelerate the fight against cancer. This CME-accredited event bridges groundbreaking research with clinical applications, fostering collaboration across academia, industry, and patient advocacy.
Theme: “Precision Oncology: Advancing Personalized Cancer Care Worldwide”
Register Now | Submit Abstract
Why Attend?
💡 Transformative Learning
- Keynotes by Nobel Laureates & WHO policy makers
- 50+ sessions on immunotherapy, liquid biopsies, and AI-driven diagnostics
- CME/CPD accreditation for healthcare professionals
🌍 Global Networking
- Connect with 1000+ attendees from 60+ countries
- B2B matchmaking with pharma/biotech leaders
- Poster awards with publication opportunities
🚀 Innovation Showcase
- Tech exhibition featuring CRISPR and CAR-T breakthroughs
- Startup pitch competitions ($50K innovation prize)
- Interactive VR demonstrations of surgical robotics
Conference Highlights
Scientific Tracks
🔬 Translational Research
🧪 Precision Medicine & Genomics
💊 Clinical Trials & Novel Therapies
🩺 Palliative & Supportive Care
🤖 Digital Oncology & AI
Special Programs
- Young Investigator Forum (Under 35)
- Women in Oncology Leadership Summit
- Global Cancer Policy Roundtable
Who Should Attend?
👨⚕️ Oncologists & Surgeons
🔍 Research Scientists
🏛️ Academic Faculty
💼 Biotech/Pharma Executives
👩🔬 Clinical Trial Specialists
🌱 Startup Founders
📚 Students & Fellows
Benefits of Participation
Global Visibility
Enhance your professional and research profile through international exposure.Personalized Participant Webpage
Each participant will receive a dedicated webpage showcasing their profile and contributions.Full Conference Access
Enjoy complete access to all sessions of the conferenceAccredited Certificate
Receive an official accreditation certificate from the Organizing Committee.Abstract Publication
Abstracts will be published in the conference souvenir and selected international journals.Global Networking Opportunities
Connect with leading oncologists, researchers, clinicians, and industry professionals worldwide.“Ask the Expert” Sessions
Participate in pre-scheduled one-to-one interactive discussions with international experts.Post-Conference Engagement
Gain access to the attendees’ email list to foster long-term professional collaborations.Knowledge Enrichment
Learn from keynote lectures, expert panels, technical sessions, and interactive workshops.Latest Advances in Oncology
Gain insights into precision oncology, cancer biology, targeted therapies, and clinical advancements.CME & CPD Credits
Earn CME and CPD credits (subject to approval).Awards & Recognition
Outstanding researchers and students will be recognized with awards and certificates.Career Development
Expand career opportunities through international exposure and collaborative research.Industry & Branding Exposure
Explore business opportunities, industry collaborations, and global branding prospects.
Present Your Work:
- Abstract Submission Deadline: May 18, 2026
- Competitive poster awards with publication opportunities
Key Statistics
📅 Date: June 05-06, 2026
📍 Location: Online
👥 Attendees: 100+ Expected
🌐 Countries Represented: 60+
Hosted By
Globemeet Research Conferences – Leaders in curating high-impact medical summits across:
- Oncology & Haematology
- Precision Medicine
- Healthcare Innovation
Sessions & Tracks:
Track 1: Immuno-Oncology Breakthroughs
Track 2: Precision Medicine & Targeted Therapies
Track 3: Cancer Stem Cell Biology
Track 4: Metabolic Reprogramming in Cancer
Track 5: Next-Gen Radiation Oncology
Track 6: Cancer Prevention & Global Epidemiology
Track 7: Paediatric & AYA Oncology Innovations
Track 8: AI/ML in Cancer Diagnostics
Track 9: Clinical Trial Design & Novel Therapeutics
Track 10: Oncology Nursing Excellence
Track 11: Tumor Immunology & Microenvironment
Track 12: Therapeutic Cancer Vaccines
Track 13: Mechanisms of Drug Resistance
Track 14: Bioethics & Regulatory Science
Track 15: Multi-Omics in Oncology (Genomics/Proteomics/Metabolomics)
Track 16: Cancer Data Science & Digital Pathology
Track 17: CAR-T & Cellular Therapies
Track 18: Emerging Oncology Technologies
Track 19: Supportive & Palliative Care Advances
Track 20: Gut Microbiome & Cancer
Track 21: Digital Health & Remote Monitoring
Track 22: Psycho-Oncology & Survivorship Care
Track 23: Interventional Radiology Innovations
Track 24: Future Horizons in Cancer Research
Track 25: Metastasis & Circulating Tumor Cells
Track 26: Nanomedicine Applications
Track 27: Patient-Centered Outcomes Research
Track 28: Liquid Biopsy & Early Detection
Track 29: Biomarker Discovery & Validation
Track 30: Survivorship & Quality-of-Life Science
Industry Overview
International Conference on Cancer Research & Therapy (CRT-2026) arrives at a pivotal moment in cancer research, as the market surges toward $300 billion by 2028 (CAGR: 8.3%). This growth is propelled by:
- Rising global cancer burden (20M+ new cases annually, WHO 2023)
- Breakthroughs in immunotherapy & targeted therapies
- AI-driven drug discovery acceleration
Key Market Segments
By Therapy Type
Segment | 2023 Market Share | Growth Driver |
Immunotherapy | 32% | CAR-T & checkpoint inhibitors |
Targeted Therapy | 28% | Biomarker-driven treatments |
Chemotherapy | 22% | Generic drug accessibility |
Hormone Therapy | 18% | Breast/prostate cancer demand |
By Cancer Type
- Lung Cancer (23% revenue share)
- Breast Cancer (19%)
- Colorectal (15%)
- Prostate (12%)
- Others (31%)
Regional Hotspots
🌎 North America (45% market share)
- Drivers: FDA fast-track approvals, precision medicine adoption
🇪🇺 Europe (30%)
- Trend: EU’s Cancer Mission funding (€4B+ investment)
🌏 Asia-Pacific (Fastest CAGR: 11.2%)
- Opportunity: Expanding healthcare infrastructure
Top 5 Market Trends
- Precision Oncology (70% of new trials are biomarker-based)
- AI in Drug Discovery (Reducing timelines by 40%)
- Bispecific Antibodies ($12B pipeline by 2026)
- Liquid Biopsy Adoption (25% annual growth)
- Microbiome Therapeutics (200+ clinical trials ongoing)
Why CRT-2026 Matters for Industry Stakeholders
For Researchers
- Showcase findings to 50+ pharma partners
- Access $2.3B in venture funding (2024 oncology startups)
For Clinicians
- Learn CME-accredited therapeutic protocols
- Explore real-world AI diagnostic tools
For Industry
- Scout 15+ pitch competitions for acquisitions
- Preview Phase III trial data from top 10 biotechs
Seize the Opportunity
📈 Exhibit: Launch products to 1,500+ decision-makers
🤝 Partner: Connect with 300+ research institutions
💡 Invest: Discover pre-commercial technologies
Past Conference Report
International Conference on Cancer Research & Therapy 2025
December 05–06, 2025 | Online Event
Theme: “Precision Oncology: From Discovery to Global Impact”
Globemeet Research Conferences extends its heartfelt appreciation to all keynote speakers, researchers, delegates, academicians, clinicians, and industry professionals who contributed to the successful execution of the International Conference on Cancer Research & Therapy 2025, held virtually on December 05–06, 2025.
We are deeply thankful to our distinguished speakers for their valuable scientific contributions and active participation throughout the conference sessions:
Dr. Mohadeseh Haji Abdolvahab, Motamed Cancer Institute, Iran
Dr. Neha, SGT University, India
Dr. Alka Ahuja, National University of Science and Technology, Oman
Dr. Sushama Jadhav, ICMR-National Institute of Translational Virology and AIDS Research, India
Mr. Srinivas Bishoyi, Utkal University, India
Dr. Forough Shahmohammad, Tehran University of Medical Sciences, Iran
Mr. Omar alqaisi, Al-Zaytoonah University of Jordon, Jordon
Dr. Medha Jha, Delhi Technological University, India
Dr. Patricia Tai, University of Saskatchewan, Canada
Dr. Sarah Eliuth Ochoa-Hugo, CIATEJ Guadalajara, Mexico
The conference served as a distinguished global forum for the exchange of scientific knowledge and clinical expertise in oncology. It brought together leading experts from academia, hospitals, research institutions, and the pharmaceutical and biotechnology industries to discuss recent breakthroughs, ongoing challenges, and future directions in cancer research and therapy.
The scientific sessions emphasized cutting-edge developments in precision oncology, including cancer genomics, molecular diagnostics, targeted therapies, immuno-oncology, translational research, and personalized cancer care. The discussions highlighted how innovative discoveries are being translated from laboratory research to clinical practice, ultimately improving patient outcomes and global cancer management strategies.
The conference witnessed active engagement through keynote lectures, oral and poster presentations, panel discussions, and interactive Q&A sessions. Participants from across the globe shared insights, fostered interdisciplinary collaborations, and explored opportunities for advancing cancer research and therapeutic approaches worldwide.
The overwhelming participation and positive feedback from international attendees underscored the growing importance of precision medicine in oncology and the need for continued global collaboration to address the evolving cancer burden.
Encouraged by the success of the 2025 edition, Globemeet Research Conferences is pleased to announce the 2nd International Conference on Cancer Research & Therapy 2026, scheduled to take place on June 05–06, 2026 | Online Event | London, UK.
Theme:
“Precision Oncology: Advancing Personalized Cancer Care Worldwide”
We cordially invite researchers, clinicians, healthcare professionals, industry experts, and students to join us once again for an enriching scientific experience, thought-provoking discussions, and meaningful collaborations at the 2nd International Conference on Cancer Research & Therapy 2026.
Let us come together again in June 2026 to advance the future of cancer research and personalized care.
Speaker Opportunities : Oral Presentation, Poster Presentation, E-Poster
Why To Choose Globemeet Research Conferences
What We Do?
Globemeet Research Conferences is committed to revitalizing and advancing knowledge in the fields of Science, Engineering, and Technology. Our goal is to bridge the gap between past discoveries, present research, and future innovation by creating a platform that fosters meaningful scientific exchange.
Who We Are?
Globemeet Research Conferences specializes in organizing scientific conferences, seminars, and workshops worldwide to promote networking and knowledge sharing—bringing together researchers, dynamic educators, passionate academicians, dedicated scholars, innovators, and research professionals to discuss, showcase, and strengthen emerging technologies.
What Is Our Vision?
Globemeet Research Conferences follows the core values of KPR — K for Knowledge in science and technology, P for Passion in scientific research, and R for Revolution in global scientific events. Our aim is to bring together the scientific community and industry experts worldwide to collaboratively address current public health challenges and explore effective scientific solutions.
What Is Our Mission?
Globemeet Research Conferences is dedicated to hosting events that are both highly professional and engaging, offering a trusted platform for our distinguished speakers, emerging researchers, delegates, exhibitors, and sponsors. We strive to deliver exceptional service standards and organize global scientific knowledge in a structured, impactful manner—making it universally accessible to the entire scientific community.
Renowned Speakers
Karen Craig
The University of New Mexico, Mexico
Daniel H. Ahn
Mayo Clinic, USA
Mr. Srinivas Bishoyi
Utkal University, India
Dr. Alka Ahuja
National University of Science and Technology, Oman
Dr. Ying Liang
Sun Yat-sen University, China
Dr. Sarah Eliuth Ochoa Hugo
CIATEJ Guadalajara, Mexico
Dr. Patricia Tai
University of Saskatchewan, Canada
Omar alqaisi
Al-Zaytoonah University of Jordon, Jordon
Dr. Neha
SGT University, India
Dr. Mohadeseh Haji Abdolvahab
Motamed Cancer Institute, Iran
Key Topics
- Advances In Head And Neck Cancer Surgery
- Advances In Neuroblastoma And Wilms Tumor
- Advances In PET, CT, And MRI Imaging
- AI And Machine Learning In Cancer Diagnosis
- Angiogenesis And Tumor Vascularization
- Artificial Intelligence In Oncology
- Big Data And Bioinformatics In Cancer Research
- Biopsy Techniques And Diagnostic Challenges
- Cancer Cell Biology And Tumor Microenvironment
- Cancer Registries And Epidemiological Surveillance
- Cancer Research Funding And Global Collaboration
- Cancer Stem Cells And Tumor Initiation
- Cancer Vaccines And Preventive Strategies
- CAR-T Cell Therapy And Cell-Based Treatments
- Chemotherapy: Innovations And Resistance
- Clinical Trials And Translational Oncology
- Combination Therapy Approaches
- CRISPR And Gene Editing In Oncology
- Disparities In Cancer Care Across Regions
- DNA Repair Mechanisms And Genomic Instability
- Early Detection And Screening Methods
- End-of-Life Decision-Making And Ethics
- Genetic And Epigenetic Changes In Cancer
- Pathological Grading And Histopathological Tools
- Tumor Profiling And Precision Diagnostics
- Genetic Counseling And Testing
- Genetic Syndromes And Rare Tumor Biology
- Health Economics And Cost-Effectiveness In Oncology
- Hormonal Therapy In Breast And Prostate Cancer
- Immunotherapy And Checkpoint Inhibitors
- Lifestyle And Environmental Risk Factors
- Liquid Biopsy And Circulating Tumor Cells
- Long-Term Follow-Up And Survivorship Care Plans
- Lymph Node Dissection And Sentinel Node Biopsy
- Minimally Invasive And Robotic Cancer Surgery
- Molecular And Genetic Biomarkers
- Molecular Pathways Of Oncogenesis
- Nanomedicine For Targeted Drug Delivery
- Neoadjuvant And Adjuvant Therapies
- Nutritional Support And Rehabilitation
- Oncology Education And Training Programs
- Oncoplastic Surgery And Reconstruction
- Oncoviruses And Cancer Development
- Optical Imaging And Nanodiagnostics
- Organoids And 3D Tumor Models
- Orphan Drug Development For Rare Cancers
- Pain And Symptom Management In Advanced Cancer
- Tumor Profiling And Precision Diagnostics
- Patient Advocacy And Engagement
- Pediatric Oncology: Diagnosis And Management
- Personalized And Precision Oncology
- Psycho-Oncology And Quality Of Life
- Public Health Policies And Screening Programs
- Radiotherapy: Techniques And Toxicity Management
- Role Of Non-coding RNAs In Cancer
- Surgical Approaches In GI And Colorectal Cancers
- Survivorship And Late Effects In Childhood Cancer
- Targeted Therapy And Small Molecule Inhibitors
- Tobacco And Alcohol-Related Cancers
- Tumor Heterogeneity And Clonal Evolution
- Tumor Immunology And Immune Escape
- Gut Microbiome And Cancer Therapy Response
- Tele-Oncology And Remote Patient Monitoring
- Bispecific Antibodies In Cancer Treatment
- Ferroptosis Induction As Therapeutic Strategy
- Exosome-Based Diagnostics And Therapeutics
- Senolytics For Age-Related Cancer Risk
- VR/AR For Surgical Planning And Patient Education
- Space Oncology And Radiation Effects
- LGBTQ+ Inclusive Cancer Care Practices
- Climate Change And Emerging Cancer Risks
Indexing Partners Supporters
About US
Globemeet Research Conferences is dedicated to revitalizing and advancing knowledge in the fields of Science, Engineering, and Technology. Our mission is to bridge the gap between past discoveries and future innovations by showcasing current research and shaping the next era of applied science